SLI
|
1 995,87
|
-10,16
|
-0,51 %
|
Analysen zu SLI-Werten
| 09.07.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 09.07.25 | ams-OSRAM Buy | Deutsche Bank AG | |
| 09.07.25 | Richemont Outperform | Bernstein Research | |
| 09.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 08.07.25 | ABB Neutral | UBS AG | |
| 08.07.25 | Richemont Outperform | Bernstein Research | |
| 08.07.25 | Roche Sell | Deutsche Bank AG | |
| 08.07.25 | Givaudan Equal Weight | Barclays Capital | |
| 07.07.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.07.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 04.07.25 | Novartis Buy | Deutsche Bank AG | |
| 04.07.25 | ABB Sector Perform | RBC Capital Markets | |
| 03.07.25 | Novartis Neutral | UBS AG | |
| 03.07.25 | UBS Outperform | RBC Capital Markets | |
| 03.07.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 02.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | Zurich Insurance Sell | Goldman Sachs Group Inc. | |
| 01.07.25 | Nestlé Hold | Deutsche Bank AG | |
| 01.07.25 | Richemont Sector Perform | RBC Capital Markets | |
| 01.07.25 | Roche Buy | UBS AG | |
| 01.07.25 | Novartis Neutral | UBS AG | |
| 30.06.25 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.06.25 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 30.06.25 | UBS Buy | Jefferies & Company Inc. | |
| 30.06.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.06.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 27.06.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 27.06.25 | ams-OSRAM Buy | UBS AG | |
| 27.06.25 | Richemont Outperform | Bernstein Research | |
| 26.06.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 25.06.25 | ABB Sell | Deutsche Bank AG | |
| 25.06.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 24.06.25 | Nestlé Neutral | UBS AG | |
| 23.06.25 | ABB Underperform | Bernstein Research | |
| 23.06.25 | Givaudan Hold | Deutsche Bank AG | |
| 23.06.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.06.25 | Novartis Buy | Deutsche Bank AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.